IL51339A - 3-(substituted)methylene-4-oxa-1-azabicyclo(3.2.0)heptan-7-one derivatives their preparation and pharmaceutical compositions containing them - Google Patents

3-(substituted)methylene-4-oxa-1-azabicyclo(3.2.0)heptan-7-one derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL51339A
IL51339A IL51339A IL5133977A IL51339A IL 51339 A IL51339 A IL 51339A IL 51339 A IL51339 A IL 51339A IL 5133977 A IL5133977 A IL 5133977A IL 51339 A IL51339 A IL 51339A
Authority
IL
Israel
Prior art keywords
heptan
azabicyclo
oxa
methylene
derivatives
Prior art date
Application number
IL51339A
Other languages
English (en)
Other versions
IL51339A0 (en
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of IL51339A0 publication Critical patent/IL51339A0/xx
Publication of IL51339A publication Critical patent/IL51339A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL51339A 1976-02-04 1977-01-26 3-(substituted)methylene-4-oxa-1-azabicyclo(3.2.0)heptan-7-one derivatives their preparation and pharmaceutical compositions containing them IL51339A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB4320/76A GB1529913A (en) 1976-02-04 1976-02-04 Beta-lactam compounds
GB859776 1976-03-04
GB1534676 1976-04-14
GB2422776 1976-06-11

Publications (2)

Publication Number Publication Date
IL51339A0 IL51339A0 (en) 1977-03-31
IL51339A true IL51339A (en) 1980-03-31

Family

ID=27447370

Family Applications (1)

Application Number Title Priority Date Filing Date
IL51339A IL51339A (en) 1976-02-04 1977-01-26 3-(substituted)methylene-4-oxa-1-azabicyclo(3.2.0)heptan-7-one derivatives their preparation and pharmaceutical compositions containing them

Country Status (15)

Country Link
US (1) US4206120A (da)
JP (1) JPS5297994A (da)
AT (1) AT352875B (da)
AU (1) AU506250B2 (da)
BE (1) BE850942A (da)
CH (1) CH636357A5 (da)
DE (1) DE2704104A1 (da)
DK (1) DK46677A (da)
ES (1) ES455625A1 (da)
FR (1) FR2340321A1 (da)
GB (1) GB1529913A (da)
IE (1) IE44460B1 (da)
IL (1) IL51339A (da)
NL (1) NL7701191A (da)
SE (1) SE7701216L (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1136132A (en) * 1975-02-17 1982-11-23 Teruji Tsuji Cyclization to form cephem ring and intermediates therefor
GB1593275A (en) * 1976-10-22 1981-07-15 Glaxo Lab Ltd Clavam derivatives
EP0000615B1 (en) * 1977-07-23 1981-04-29 Beecham Group Plc Beta-lactam compounds, preparation and use in pharmaceutical compositions and as chemical intermediates
DE2861335D1 (en) * 1977-11-29 1982-01-21 Beecham Group Plc Clavulanic acid derivatives, a process for their preparation and compositions containing them
NZ189022A (en) * 1977-12-08 1981-11-19 Beecham Group Ltd Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder
EP0024372A1 (en) * 1979-08-03 1981-03-04 Beecham Group Plc Derivatives of clavulanic acid, their preparation and pharmaceutical compositions containing them
EP0025287A1 (en) * 1979-08-21 1981-03-18 Beecham Group Plc Clavulanic acid derivatives, their preparation, pharmaceutical compositions containing them and their preparation
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
EP0057664A3 (de) * 1981-01-30 1982-11-17 Ciba-Geigy Ag Clavam-Derivate
DE3725375A1 (de) * 1987-07-31 1989-02-09 Bayer Ag Stabile oxapenem-3-carbonsaeuren
GB9421816D0 (en) * 1994-10-29 1994-12-14 Smithkline Beecham Plc Novel compounds
FR2739851B1 (fr) * 1995-10-13 1997-11-21 Oreal Nouveaux derives alkyl-3-oxo-alcanoates et leur procede de preparation
CA2190570C (en) 1995-11-17 2005-05-03 Yutaka Honda Process for producing 3-amino-2-oxo-1-halogenopropane derivatives
US9120808B2 (en) 2009-09-15 2015-09-01 Nabriva Therapeutics Ag Substituted clavulanic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1542405A (en) * 1975-04-15 1979-03-21 Beecham Group Ltd Clavulanic acid derivatives

Also Published As

Publication number Publication date
CH636357A5 (de) 1983-05-31
SE7701216L (sv) 1977-08-05
FR2340321A1 (fr) 1977-09-02
FR2340321B1 (da) 1980-03-07
US4206120A (en) 1980-06-03
GB1529913A (en) 1978-10-25
IE44460L (en) 1977-08-04
DE2704104A1 (de) 1977-08-11
DK46677A (da) 1977-05-16
AU506250B2 (en) 1979-12-20
JPS5297994A (en) 1977-08-17
ATA65177A (de) 1979-03-15
IE44460B1 (en) 1981-12-02
ES455625A1 (es) 1978-05-16
AT352875B (de) 1979-10-10
BE850942A (fr) 1977-08-01
IL51339A0 (en) 1977-03-31
NL7701191A (nl) 1977-08-08
AU2193177A (en) 1978-08-10

Similar Documents

Publication Publication Date Title
IL56206A0 (en) New 1,2-benzothiazine-1,1-doxide derivatives, their preparation and pharmaceutical compositions containing them
IL55465A (en) 2-alkyl-4-hydroxy-n-heteroaryl-2h-thieno(1,2)-thiazine-3-carboxamide 1,1-dioxide derivatives,their preparation and pharmaceutical compositions containing them
IL53639A (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL51463A (en) Insecticidal compositions containing n-benzyl-n-methyl-2-propynylamine derivatives,several novel n-benzyl-n-methyl-2-propynylamine derivatives and their preparation
PH16519A (en) 1,2,3,4-tetrahydro-2-amino-5-oxy-naphthalene derivatives and their pharmaceutical compositions
IL53043A (en) N-heterocyclylalkyl-(1-aryloxy-2-hydroxy-3-amino-propane)derivatives,their preparation and pharmaceutical compositions containing them
IL51339A (en) 3-(substituted)methylene-4-oxa-1-azabicyclo(3.2.0)heptan-7-one derivatives their preparation and pharmaceutical compositions containing them
IL52466A (en) 7(2-acyl-2-hydroxyiminoacetamido)-3-tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL51309A0 (en) New 1,2-benzisothiazolin-3-ones,their preparation and pharmaceutical compositions containing them
IL49325A (en) 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them
IL49424A0 (en) 1,1,1-triaryl-alkylamines,their preparation and pharmaceutical compositions containing them
NZ182555A (en) Spiro(1,3-dioxalane-4,3)-quinuclidine derivatives and pharmaceutical compositions
NZ188974A (en) 1,2,3,4,6,7,12,12b-octahydro(2,3-aquinolizine derivatives and pharmaceutical compositions
IL52717A (en) Derivatives of2-phenylamino-imidazoline-(2),their preparation and pharmaceutical compositions containing them
PH14576A (en) 9-(3-(3,5-cis-dimethylpiperazino)prophyl)carrazole,salts and solvates thereof and pharmaceutical compositions containing same
IL50230A (en) 4,5-diphenyl-2-(substituted thio-sulfonyl)imidazole derivatives their preparation and pharmaceutical compositions containing them
IL52857A (en) Oxo-benzopyrane derivatives,their preparation and pharmaceutical compositions containing them
IL56856A (en) 4,5-diaryl-pyrrole derivatives,their preparation and pharmaceutical compositions containing them
IL49132A (en) 16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them
IL54358A (en) 1-substituted-3-amino-6,7-dialkoxy-1h-1,2,4-benzothiadiazine-1-oxides,their preparation and pharmaceutical compositions containing them
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
IL55104A (en) 1,2,4-oxadiazole derivatives,their preparation and pharmaceutical compositions containing them
IL51468A (en) 17 -hydroxy- -d-homosteroid derivatives,their preparation and pharmaceutical compositions containing them
IL50464A0 (en) New 1,2,4-oxadiazin-5-one derivatives their preparation and herbicidal compositions containing them
IL53674A (en) 3-(4-phenylpiperazinyl or 4-phenylpiperidyl) o-propyloximes,their preparation and pharmaceutical compositions comprising them